ClinicalTrials.Veeva

Menu

Evaluation of Consumption of Sevoflurane in Chronic Obstructive Pulmonary Disease Patients (SevoCOPD)

E

Employee's State Insurance Corporation, New Delhi

Status

Not yet enrolling

Conditions

Chronic Obstructive Pulmonary Disease

Treatments

Device: Capnography

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT06108973
00127102023

Details and patient eligibility

About

All the Patients undergoing General Anesthesia and the patients who are having Chronic Obstructive Pulmonary Disease will be considered for this study. The Volume consumption of Sevoflurane will be studied in accordance with age, sex, duration , type of surgery, site of surgery and BMI.The volume consumption of sevoflurane is compared with Chronic Obstructive Pulmonary Disease and Normal Patients .

Full description

Chronic Obstructive pulmonary disease is known to escalate the consumption of Inhalation Agents in General Anesthesia. Hence the Data to Collect the Official Record

Enrollment

45 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Both Sex All Age Group Patient willing to give consent COPD patient

Exclusion criteria

  • Not willing to give consent Cancerous Lung Lung Lobectomy

Trial design

45 participants in 2 patient groups

Normal Patients
Description:
Normal patients without any Lung Pathology for General Anesthesia
Treatment:
Device: Capnography
COPD patients
Description:
Established Chronic Obstructive Pulmonary Disease for General Anesthesia
Treatment:
Device: Capnography

Trial contacts and locations

0

Loading...

Central trial contact

Santhosh Kumar T N, BSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems